Related Experiment Video
Updated: Sep 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a
Huqun1, Yoshiyuki Endo, Hong Xin
1Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging and Cancer, Tohoku University, Aoba-ku, Sendai 980-8575, Japan.
Abstract:
p73, a close homolog of p53 tumor suppressor, induces growth arrest and apoptosis. However, its role in cancers is controversial because of the rarity of p73 mutations, lack of tumors in p73-knockout mice, and the presence of multiple isotypes, among which Delta N isotypes inhibit the function of TA isotypes. We analyzed three naturally occurring p73 mutants found in lung cancer cell lines, NCI-H1155, DMS 92 and A427. NCI-H1155 is a cell line that has a p73 mutation [p73(G264W)] in the DNA-binding domain, as well as a p53 mutation [p53(R273H)], which is frequently found in human cancers and has a "gain-of-function" characteristic. p73 alpha(G264W) not only lacks transactivation activity itself, but also suppressed the transactivation activity of the wild-type p73 alpha in a dose-dependent manner, indicating that p73 alpha(G264W) is a dominant-negative mutant. p73 alpha(G264W) failed to suppress colony formation. We tested two other mutations, p73(Del418) in DMS 92 and p73(Del603) in A427. Both mutants retained similar levels of transactivation activity and suppression of colony formation to those of wild-type p73. The biological significance of these two mutations is unclear. In NCI-H1155 cells the coexistence of mutations that abrogate the normal functions of p73 and p53 may indicate that each mutation confers an additive growth advantage upon the cells.
Insights
The p73 tumor suppressor
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The tumor suppressor p73, a homolog of p53, plays a role in cell growth and apoptosis, but its function in cancer is debated.
- Multiple p73 isotypes exist, with Delta N isotypes potentially inhibiting TA isotypes, complicating its role.
- The rarity of p73 mutations and lack of tumors in knockout mice add to the controversy surrounding its cancer relevance.
Purpose of the Study:
- To investigate the functional impact of naturally occurring p73 mutants found in lung cancer cell lines.
- To analyze the effects of specific p73 mutations on transactivation activity and colony formation suppression.
- To understand the combined effect of p73 and p53 mutations in lung cancer progression.
Main Methods:
- Analysis of three naturally occurring p73 mutants from lung cancer cell lines (NCI-H1155, DMS 92, A427).
- Characterization of p73 alpha(G264W) mutant in NCI-H1155 cells, assessing its transactivation activity and dominant-negative potential.
- Evaluation of p73(Del418) and p73(Del603) mutants in DMS 92 and A427 cells for transactivation and colony formation suppression.
Main Results:
- The p73 alpha(G264W) mutant in NCI-H1155 cells demonstrated loss of transactivation and dominant-negative inhibition of wild-type p73 alpha.
- p73 alpha(G264W) failed to suppress colony formation, indicating a loss of tumor suppressor function.
- Mutations p73(Del418) and p73(Del603) retained wild-type levels of transactivation and colony formation suppression, with unclear biological significance.
- NCI-H1155 cells harbor both p73 and p53 mutations, suggesting an additive growth advantage.
Conclusions:
- The p73 alpha(G264W) mutation acts as a dominant-negative mutant, impairing wild-type p73 alpha function and contributing to cancer cell growth.
- The biological significance of p73(Del418) and p73(Del603) mutations requires further investigation.
- Co-occurring p73 and p53 mutations in lung cancer may confer an additive growth advantage, highlighting the complex interplay of tumor suppressors in cancer development.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle

